Tirzepatide + B6

Price range: $199.00 through $449.00

Initial charge of $39 for consultation. Medication is charged only after provider approval.

A personalized, once-weekly prescription treatment combining Tirzepatide with vitamin B6. Tirzepatide activates both GIP and GLP-1 receptors involved in appetite regulation and metabolic function. Vitamin B6 supports several normal metabolic processes, including protein metabolism, neurotransmitter production, immune function, and hemoglobin formation.

Not Available in: AL, MS, NV, ND, OH

Tirzepatide + B6 is a prescription-only compounded medication intended for eligible patients participating in a clinician-guided weight-management program. Tirzepatide is a dual GIP and GLP-1 receptor agonist. It affects biological pathways involved in appetite, caloric intake, insulin response, and gastric emptying. Vitamin B6 is an essential nutrient involved in more than 100 enzyme reactions. It contributes to normal protein, carbohydrate, and lipid metabolism and supports neurotransmitter production, immune function, and hemoglobin formation. The inclusion of B6 should not be interpreted as evidence that this formulation produces greater weight loss or fewer side effects than Tirzepatide alone. Your provider will determine whether this formulation is clinically appropriate based on your health history, medications, nutritional considerations, and treatment goals. Important note: Compounded medications are not reviewed or approved by the FDA. This medication is prepared for an individual patient by a licensed compounding pharmacy following a provider’s prescription.

This formulation combines Tirzepatide’s dual-pathway activity with the established nutritional functions of vitamin B6. Tirzepatide

  • Activates GIP and GLP-1 receptors
  • Supports appetite regulation and reduced caloric intake
  • Delays gastric emptying
  • Supports glucose-dependent insulin secretion
  • Reduces glucagon secretion
  • Supports insulin sensitivity and metabolic function
Vitamin B6
  • Participates in normal protein and amino-acid metabolism
  • Contributes to carbohydrate and lipid metabolism
  • Supports neurotransmitter production
  • Supports normal immune function
  • Contributes to hemoglobin formation
Vitamin B6 is a supportive ingredient and is not the active weight-management component of the formulation.

Tirzepatide + B6 may be considered when a licensed provider determines that a patient-specific compounded formulation is clinically appropriate. Potential treatment features include:

  • Dual GIP and GLP-1 receptor activity
  • Once-weekly subcutaneous administration
  • Personalized dosing and titration
  • Licensed-provider evaluation and monitoring
  • At-home administration after proper instruction
  • Fulfillment through a licensed U.S. compounding pharmacy
  • Ongoing access to Pentavia’s clinical support team
The Tirzepatide + B6 formulation has not been shown to be clinically superior to Tirzepatide alone or to Tirzepatide combined with B12.

Eligibility is determined by a licensed provider after reviewing your health history, current medications, BMI, weight-related health conditions, and treatment goals. The general populations studied for FDA-approved Tirzepatide weight-management treatment include: BMI General guidance Below 27 Generally outside standard weight-management criteria 27–29.9 May qualify with at least one weight-related health condition 30 or higher May qualify, subject to clinical review Weight-related conditions may include high blood pressure, abnormal cholesterol levels, obstructive sleep apnea, cardiovascular disease, or type 2 diabetes. This chart is provided only as general guidance. It does not guarantee eligibility, a prescription, or access to a compounded formulation.

Use Tirzepatide + B6 exactly as directed by your prescribing provider and dispensing pharmacy. General administration may include:

  • Injecting the prescribed dose once weekly under the skin
  • Using the abdomen or thigh as an injection site
  • Having another person administer the injection in the back of the upper arm
  • Rotating injection sites with each dose
  • Following a personalized titration schedule
  • Using a new sterile syringe and needle for each injection
Do not rely on dosage instructions from another Tirzepatide product. Concentration, injection volume, storage requirements, and beyond-use dates can differ between compounded formulations. Follow the instructions printed on your prescription label and included by the dispensing pharmacy.

Your treatment package may include:

  • A multi-dose vial of prescribed Tirzepatide + B6
  • Syringes and injection needles
  • Alcohol preparation pads
  • Personalized dosing and titration instructions
  • Temperature-controlled, discreet shipping when required
  • Access to Pentavia’s clinical support team
Final kit contents, vial concentration, supplies, shipping method, and storage instructions must be confirmed with the dispensing pharmacy.

How is Tirzepatide + B6 different from Tirzepatide + B12? Both formulations use Tirzepatide as the primary treatment ingredient. The difference is the accompanying vitamin. The B12 formulation contains vitamin B12, while the B6 formulation contains vitamin B6. These vitamins perform different nutritional functions in the body. There is currently no established evidence that adding B6 makes Tirzepatide more effective for weight loss or more tolerable than Tirzepatide alone or Tirzepatide + B12. Your provider will determine which available formulation is appropriate for you. Is compounded Tirzepatide + B6 FDA-approved? No. Compounded Tirzepatide + B6 is not FDA-approved. The FDA does not evaluate compounded drugs for safety, effectiveness, manufacturing quality, or equivalence to an FDA-approved medication before they are dispensed. FDA-approved medications containing Tirzepatide are separate products and should not be presented as interchangeable with a compounded formulation. Is Tirzepatide + B6 safe for long-term use? Long-term treatment decisions must be made by a licensed provider. FDA-approved Tirzepatide has been evaluated in clinical studies, but a specific compounded Tirzepatide + B6 formulation has not undergone FDA review. Safety also depends on the exact concentration, ingredients, pharmacy preparation, patient history, other medications, and ongoing monitoring. Your provider should periodically evaluate treatment response, side effects, hydration, nutritional intake, blood-glucose medications, and whether continued treatment remains appropriate. When might I notice changes? Individual experiences vary. Some patients may notice changes in appetite or fullness before observing meaningful changes in weight or metabolic measurements. Your provider will monitor your response and may gradually adjust your dose based on tolerability and clinical progress. No specific result or timeline can be guaranteed. Can I transition to an FDA-approved Tirzepatide product later? Potentially. Your provider can discuss FDA-approved treatment options and determine whether transitioning is clinically appropriate. Do not switch products, concentrations, or doses without provider instructions. A compounded vial and an FDA-approved Tirzepatide product may have different concentrations, delivery systems, and dosing instructions.

Do Not Use This Medication If You:

  • Have a personal or family history of medullary thyroid carcinoma
  • Have Multiple Endocrine Neoplasia syndrome type 2
  • Have experienced a serious allergic reaction to Tirzepatide, vitamin B6, or another ingredient in the prescribed formulation
  • Are pregnant or become pregnant during treatment
Tell Your Provider Before Treatment If You:
  • Have or have had pancreatitis
  • Have gallbladder disease
  • Have severe gastrointestinal problems, including gastroparesis
  • Have kidney problems or are at risk of dehydration
  • Have type 2 diabetes or diabetic retinopathy
  • Use insulin, a sulfonylurea, or another medication that lowers blood sugar
  • Take oral medications that could be affected by delayed gastric emptying
  • Use oral hormonal contraceptives
  • Are breastfeeding or planning to breastfeed
  • Are scheduled for surgery, anesthesia, or deep sedation
  • Take supplements or medications containing vitamin B6
  • Have unexplained numbness, tingling, burning sensations, or balance problems
Excessive or prolonged vitamin B6 exposure can cause sensory neuropathy. Your provider should consider all sources of B6, including supplements and other medications. Common Side Effects May Include:
  • Nausea
  • Diarrhea
  • Vomiting
  • Constipation
  • Abdominal discomfort or pain
  • Indigestion or heartburn
  • Decreased appetite
  • Fatigue
  • Injection-site reactions
Gastrointestinal side effects commonly occur during dose escalation and may lessen over time. Contact your provider if side effects are severe, persistent, or concerning. Seek immediate medical attention for difficulty breathing, facial or throat swelling, severe rash, fainting, or other signs of a serious allergic reaction. Seek prompt medical attention for severe, persistent abdominal pain, especially when accompanied by vomiting or pain radiating to the back.

Compounded drugs are not reviewed or approved by the FDA. The FDA does not verify their safety, effectiveness, manufacturing quality, or equivalence to an FDA-approved medication before they are marketed. Tirzepatide + B6 should only be offered when legally available and when a licensed provider determines that a patient-specific compounded formulation is clinically appropriate. Pentavia does not practice medicine or make prescribing decisions. All prescriptions and clinical decisions are made independently by licensed healthcare providers. Product concentration, ingredients, dosing, pricing, pharmacy partner, state availability, storage requirements, beyond-use date, and packaging may vary and must be confirmed before this page is published. Images are for illustrative purposes. Actual product packaging and appearance may vary by dispensing pharmacy. Individual experiences and results vary.